Inventor · disambiguated record
Dan Theodorescu
Also filed as: THEODORESCU DAN
8 granted patents·8 pending applications·11 citations·filing 2007–2023
79Inventor score
Files withUNIV COLORADO REGENTS10CEDARS SINAI MEDICAL CENTER2DEGRAFF DAVID1THE REGENTS OF THE UNIV OF THE COLORADO A BODY CORPORATE1THEODORESCU DAN1
Top patents by PatentIndex Score
16 records- 0188US9353121B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2012·Granted May 31, 2016·7 cites·6 claims
- 0287US10676480B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2019·Granted Jun 9, 2020·2 cites·22 claims
- 0378US10202397B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2015·Granted Feb 12, 2019·2 cites·8 claims
- 0474USRE48557EAnti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2019·Granted May 18, 2021·0 cites·8 claims
- 0567US11472812B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2020·Granted Oct 18, 2022·0 cites·15 claims
- 0664US11964985B2Anti-cancer compounds targeting Ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2020·Granted Apr 23, 2024·0 cites·13 claims
- 0762US2024050392A1Compositions and methods for improved treatment of platinum-based chemotherapeutic resistant tumorsTHE REGENTS OF THE UNIV OF THE COLORADO A BODY CORPORATE·Filed 2023·Application pending·0 cites
- 0859US10689392B2Anti-cancer compounds targeting ral GTPases and methods of using the sameUNIV COLORADO REGENTS·Filed 2016·Granted Jun 23, 2020·0 cites·9 claims
- 0959US2014363816A1Methods for prediction of clinical response to radiation therapy in cancer patientsUNIV COLORADO REGENTS·Filed 2012·Application pending·0 cites
- 1055US2008118576A1Prediction of an agent's or agents' activity across different cells and tissue typesTHEODORESCU DAN·Filed 2007·Application pending·0 cites
- 1155US2024115699A1Use of cancer cell expression of cadherin 12 and cadherin 18 to treat muscle invasive and metastatic bladder cancersCEDARS SINAI MEDICAL CENTER·Filed 2022·Application pending·0 cites
- 1251US2023119171A1Biomarker panels for stratification of response to immune checkpoint blockade in cancerCEDARS SINAI MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 1350US12145962B2Construction and methods of use of a barcoded and gene edited DNA libraryUNIV COLORADO REGENTS·Filed 2019·Granted Nov 19, 2024·0 cites·22 claims
- 1449US2017058360A1Methods for Prediction of Clinical Response to Radiation Therapy in Cancer PatientsUNIV COLORADO REGENTS·Filed 2016·Application pending·0 cites
- 1538US2013295590A1Foxa1 as a marker for invasive bladder cancerDEGRAFF DAVID·Filed 2011·Application pending·0 cites
- 1637US2015011411A1Biomarkers of cancerUNIV COLORADO A BODY CORP·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →